Cargando…

A Pancancer Analysis of the Oncogenic Role of S100 Calcium Binding Protein A7 (S100A7) in Human Tumors

SIMPLE SUMMARY: Although emerging studies support the relationship between S100 calcium binding protein A7 (S100A7) and various cancers, no pancancer analysis of S100A7 is available thus far. Therefore, we investigated the potential oncogenic roles of S100A7 across 33 tumors based on datasets from T...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ge, Tsukamoto, Saya, Okumura, Ko, Ogawa, Hideoki, Ikeda, Shigaku, Niyonsaba, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869593/
https://www.ncbi.nlm.nih.gov/pubmed/35205150
http://dx.doi.org/10.3390/biology11020284
Descripción
Sumario:SIMPLE SUMMARY: Although emerging studies support the relationship between S100 calcium binding protein A7 (S100A7) and various cancers, no pancancer analysis of S100A7 is available thus far. Therefore, we investigated the potential oncogenic roles of S100A7 across 33 tumors based on datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Higher levels of S100A7 were observed in most types of tumors, and importantly, S100A7 seemed to be a prognosis marker of the tumor subjects. In addition, S100A7 levels were associated with the infiltration level of CD8(+) T cells and cancer-associated fibroblasts in different tumors. Moreover, the dysregulation of glycosaminoglycan and lysosome was associated with S100A7 functional mechanisms. The current pancancer study offers a relatively integrative understanding of the carcinogenic involvement of S100A7 in numerous types of cancers. ABSTRACT: Background: Although emerging studies support the relationship between S100 calcium binding protein A7 (S100A7) and various cancers, no pancancer analysis of S100A7 is available thus far. Methods: We investigated the potential oncogenic roles of S100A7 across 33 tumors based on datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Moreover, a survival prognosis analysis was performed with the gene expression profiling interactive analysis (GEPIA) web server and Kaplan–Meier plotter, followed by the genetic alteration analysis of S100A7 and enrichment analysis of S100A7-related genes. Results: S100A7 was highly expressed in most types of cancers, and remarkable associations were found between S100A7 expression and the prognosis of cancer patients. S100A7 expression was associated with the expression of DNA methyltransferase and mismatch repair genes in head and neck squamous cell carcinoma, the infiltration of CD8(+) T cells and cancer-associated fibroblasts in different tumors. Moreover, glycosaminoglycan degradation and lysosome-associated functions were involved in the functional mechanisms of S100A7. Conclusions: The current pancancer study shows a relatively integrative understanding of the carcinogenic involvement of S100A7 in numerous types of cancers.